The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England
Open accessPublished version of a preprint
Abstract
The SARS-CoV-2 lineage B.1.1.7, designated variant of concern (VOC) 202012/01 by Public Health England 1, was first identified in the UK in late summer to early autumn 2020 2. Whole-genome SARS-CoV-2 sequence data collected from community-based diagnostic testing for COVID-19 show an extremely rapid expansion of the B.1.1.7 lineage during autumn 2020, suggesting that it has a selective advantage. Here we show that changes in VOC frequency inferred from genetic data correspond closely to changes inferred by S gene target failures (SGTF) in community-based diagnostic PCR testing. Analysis of trends in SGTF and non-SGTF case numbers in local areas across England shows that B.1.1.7 has higher transmissibility than non-VOC lineages, even if it has a different latent period or generation time. The SGTF data indicate a transient shift in the age composition of reported cases, with cases of B.1.1.7 including a larger share of under 20-year-olds than non-VOC cases. We estimated time-varying reproduction numbers for B.1.1.7 and co-circulating lineages using SGTF and genomic data. The best-supported models did not indicate a substantial difference in VOC transmissibility among different age groups, but all analyses agreed that B.1.1.7 has a substantial transmission advantage over other lineages, with a 50% to 100% higher reproduction number.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Epidemiological studies suggest that it was approximately 50% more transmissible than previously circulating UK variants 191,197,198 .”
From The biological and clinical significance of emerging SARS-CoV-2 variants (2021) · cites this paper as [191]
In the citing paper
“Volz and colleagues have shown that the B.1.1.7 variant increases the effective reproduction number, Rt, by a factor of 1·5–2·0.5”
From Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study (2021) · cites this paper as [5]
In the citing paper
“Preliminary evidence from epidemiological studies suggests that the B.1.1.7 variant is more transmissible than pre-existing variants.”
From Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study (2021) · cites this paper as [5]
In the citing paper
“In addition, the emergence of new variants with increased transmissibility 8 and reduced sensitivity to vaccine-elicited antibodies 9 , and for which vaccines are less able to prevent infection 10 , has raised fears for vulnerable groups in whom the magnitude and quality of immune responses may be suboptimal.”
From Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2 (2021) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Elements of Statistical Learning
Hastie, T., Tibshirani, R., & Friedman, J. (2009) · Springer Series in Statistics · doi:10.1007/978-0-387-84858-7 · Cited by 25,970
IQ-TREE 2: New Models and Efficient Methods for Phylogenetic Inference in the Genomic Era
Minh, B. Q., Schmidt, H. A., Chernomor, O., Schrempf, D., Woodhams, M. D., von Haeseler, A., & Lanfear, R. (2020) · Molecular Biology and Evolution · doi:10.1093/molbev/msaa015 · Cited by 16,873
Hastie, T., & Tibshirani, R. (1986) · Statistical Science · doi:10.1214/ss/1177013604 · Cited by 12,575
Posterior summarization in Bayesian phylogenetics using tracer 1.7
Rambaut, A., Drummond, A. J., Xie, D., Baele, G., & Suchard, M. A. (2018) · Systematic Biology · doi:10.1093/sysbio/syy032 · Cited by 11,159
Self-citationBayesian phylogenetic and phylodynamic data integration using BEAST 1.10
Suchard, M. A., Lemey, P., Baele, G., Ayres, D. L., Drummond, A. J., & Rambaut, A. (2018) · Virus Evolution · doi:10.1093/ve/vey016 · Cited by 3,749
Self-citationEstimating the effects of non-pharmaceutical interventions on COVID-19 in Europe
Flaxman, S. R., Mishra, S., Gandy, A., Unwin, H. J. T., Mellan, T. A., Coupland, H., Whittaker, C., Zhu, H., Berah, T., Eaton, J. W., et al. (2020) · Nature · doi:10.1038/s41586-020-2405-7 · Cited by 3,398
Self-citationEstimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
Davies, N. G., Abbott, S., Barnard, R. C., Jarvis, C. I., Kucharski, A. J., Munday, J. D., Pearson, C. A. B., Russell, T. W., Tully, D. C., Washburne, A. D., et al. (2021) · Science · doi:10.1126/science.abg3055 · Cited by 2,581
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
Davies, N. G., Abbott, S., Barnard, R. C., Jarvis, C. I., Kucharski, A. J., Munday, J. D., Pearson, C. A. B., Russell, T. W., Tully, D. C., Washburne, A. D., et al. (2020) · doi:10.1101/2020.12.24.20248822 · Cited by 2,557
Detection of a SARS-CoV-2 variant of concern in South Africa
Tegally, H., Wilkinson, E., Giovanetti, M., Iranzadeh, A., Fonseca, V., Giandhari, J., Doolabh, D., Pillay, S., San, E. J., Msomi, N., et al. (2021) · Nature · doi:10.1038/s41586-021-03402-9 · Cited by 2,510
Bi, Q., Wu, Y., Mei, S., Ye, C., Zou, X., Zhang, Z., Liu, X., Wei, L., Truelove, S., Zhang, T., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30287-5 · Cited by 1,960
Cited by
Sorted by citations
Items 801–900 of 1,003
Emergence of novel combinations of SARS-CoV-2 spike receptor binding domain variants in Senegal
Ahouidi, A. D., Rodgers, M. A., Padane, A., Lèye, N., Olivo, A., Mbow, M., Mboup, A., Diaw, P. A., Dia, A., Harris, B., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-02874-z · Cited by 11
Goethem, N. V., Vandromme, M., Oyen, H. J. V., Haarhuis, F., Brondeel, R., Catteau, L., André, E., Cuypers, L., Blot, K. Y., & Serrien, B. (2022) · PLoS ONE · doi:10.1371/journal.pone.0269138 · Cited by 11
Genomic surveillance of SARS-CoV-2 in Puerto Rico enabled early detection and tracking of variants
Santiago, G. A., Flores, B., González, G. L., Charriez, K. N., Huertas, L. C., Volkman, H. R., Belleghem, S. M. V., Rivera‐Amill, V., Adams, L. E., Marzán, M., et al. (2022) · Communications Medicine · doi:10.1038/s43856-022-00168-7 · Cited by 11
Węgrzyńska, K., Komiażyk, M., Walory, J., Kozińska, A., Waśko, I., & Baraniak, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169416 · Cited by 11
Sunagawa, J., Park, H., Kim, K. S., Komorizono, R., Choi, S., Torres, L. R., Woo, J., Jeong, Y. D., Hart, W. S., Thompson, R. N., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43043-2 · Cited by 11
Stoddard, S. V., Wallace, F. E., Stoddard, S. D., Cheng, Q., Acosta, D., Barzani, S., Bobay, M. L., Briant, J., Cisneros, C., Feinstein, S., et al. (2021) · Biophysica · doi:10.3390/biophysica1030023 · Cited by 11
Chan, C. T.-M., Leung, J. S.-L., Lee, L.-K., Lo, H. W.-H., Wong, E. Y.-K., Wong, D. S.-H., Ng, T. T.-L., Lao, H.-Y., Lu, K. K., Jim, S. H.-C., et al. (2021) · Journal of Virological Methods · doi:10.1016/j.jviromet.2021.114333 · Cited by 11
Eales, O. D., Walters, C. E., Wang, H., Haw, D., Ainslie, K. E. C., Atchison, C. J., Page, A. J., Prosolek, S. J., Trotter, A. J., Le-Viet, T., et al. (2022) · Wellcome Open Research · doi:10.12688/wellcomeopenres.17723.1 · Cited by 10
The variant‐specific burden of SARS‐CoV‐2 in Michigan: March 2020 through November 2021
Petrie, J. G., Eisenberg, M. C., Lauring, A. S., Gilbert, J., Harrison, S. M., DeJonge, P. M., & Martin, E. T. (2022) · Journal of Medical Virology · doi:10.1002/jmv.27982 · Cited by 10
Non-pharmaceutical interventions and the emergence of pathogen variants
Ashby, B., Smith, C. A., & Thompson, R. N. (2022) · Evolution Medicine and Public Health · doi:10.1093/emph/eoac043 · Cited by 11
Nidom, R. V., Indrasari, S., Normalina, I., Nidom, A. N., Afifah, B., Dewi, L., Putra, A. K., Ansori, A. N. M., Kusala, M. K. J., Alamudi, M. Y., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.26.426655 · Cited by 11
Alter, G., Gorman, M. J., Patel, N., Guebre‐Xabier, M., Zhu, A. L., Atyeo, C. G., Pullen, K. M., Loos, C., Goez-Gazi, Y., Carrion, R., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-200342/v1 · Cited by 9
Gaussian Process Nowcasting: Application to COVID-19 Mortality ReportingPreprint
Hawryluk, I., Hoeltgebaum, H., Mishra, S., Miscouridou, X., Schnekenberg, R. P., Whittaker, C., Vollmer, M., Flaxman, S. R., Bhatt, S., & Mellan, T. A. (2021) · arXiv (Cornell University) · doi:10.48550/arxiv.2102.11249 · Cited by 11
Self-citationEales, O. D., Page, A. J., Tang, S. N., Walters, C. E., Wang, H., Haw, D., Trotter, A. J., Le-Viet, T., Foster-Nyarko, E., Prosolek, S. J., et al. (2021) · medRxiv · doi:10.1101/2021.05.08.21256867 · Cited by 11
Self-citationAdvances in attractive therapeutic approach for macrophage activation syndrome in COVID-19
Chen, S., Zhang, C., Chen, D., Dong, L., Chang, T., & Tang, Z. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1200289 · Cited by 14
Parag, K. V., Cowling, B. J., & Lambert, B. C. (2023) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2023.1664 · Cited by 9
The new UK SARS-CoV-2 variant and lockdown – causes and consequences
Pan, D., Mudalige, N. L., Sze, S., Koeckerling, D., Oyefeso, O., Barker, J., Williams, C., Tang, J. W.-T., & Pareek, M. (2021) · Clinical Medicine · doi:10.7861/clinmed.2021-0019 · Cited by 9
Kim, Y.-J., Kim, E., Lee, S., & Kwon, D. (2021) · Osong Public Health and Research Perspectives · doi:10.24171/j.phrp.2021.0037 · Cited by 10
Lin, Y.-Z., Shen, Y.-C., Wu, W.-R., Wang, W., Wang, Y.-L., Lin, C.-Y., Hung, M., & Wang, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136938 · Cited by 10
Statistical Challenges in Tracking the Evolution of SARS-CoV-2
Cappello, L., Kim, J., Liu, S., & Palacios, J. A. (2022) · Statistical Science · doi:10.1214/22-sts853 · Cited by 8
Carvalho-Correia, E., Calçada, C., Branca, F., Estévez‐Gómez, N., Chiara, L. D., Varela, N., Gallego‐García, P., Posada, D., de Sousa, H. M. L., Sousa, J. C., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9101314 · Cited by 10
Zhao, S., Wang, K., Chong, K. C., Musa, S. S., He, M., Han, L., He, D., & Wang, M. H. (2022) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2022.111105 · Cited by 10
Chakraborty, C., Sharma, A. R., Bhattacharya, M., Mallik, B., Nandi, S. S., & Lee, S. (2022) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2022.105282 · Cited by 10
Carter, C., Airas, J., & Parish, C. A. (2022) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2022.108360 · Cited by 10
Veneziano, C., Marascio, N., Marco, C. D., Quaresima, B., Biamonte, F., Trecarichi, E. M., Santamaria, G., Quirino, A., Torella, D., Quattrone, A., et al. (2023) · Viruses · doi:10.3390/v15020408 · Cited by 10
The effect of SARS-CoV-2 variants on the plasma oxylipins and PUFAs of COVID-19 patients
Biagini, D., Oliveri, P., Baj, A., Gasperina, D. D., Ferrante, F. D., Lomonaco, T., Ghimenti, S., Lenzi, A., Bonini, A., Vivaldi, F. M., et al. (2023) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2023.106770 · Cited by 10
Drivers and impact of the early silent invasion of SARS-CoV-2 Alpha
Faucher, B., Sabbatini, C. E., Czuppon, P., Kraemer, M. U. G., Lemey, P., Colizza, V., Blanquart, F., Boëlle, P., & Poletto, C. (2024) · Nature Communications · doi:10.1038/s41467-024-46345-1 · Cited by 11
Dissemination and evolution of SARS‐CoV‐2 in the early pandemic phase in South America
Wolf, J. M., Streck, A. F., Fonseca, A. S. K., Ikuta, N., Simon, D., & Lunge, V. R. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26967 · Cited by 10
The evolving proteome of SARS-CoV-2 predominantly uses mutation combination strategy for survival
Patro, L. P. P., Sathyaseelan, C., Uttamrao, P. P., & Rathinavelan, T. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.05.054 · Cited by 9
Clustering Based Identification of SARS-CoV-2 Subtypes
Melnyk, A., Mohebbi, F., Knyazev, S., Sahoo, B., Hosseini, R., Skums, P., Zelikovsky, A., & Patterson, M. (2021) · Lecture notes in computer science · doi:10.1007/978-3-030-79290-9_11 · Cited by 10
Wang, J., Yang, Y., Liang, T., Yang, N., Li, T., Zheng, C. J., Ning, N., Luo, D., Yang, X., He, Z., et al. (2021) · Journal of Advanced Research · doi:10.1016/j.jare.2021.07.008 · Cited by 10
Lu, R., Zhao, L., Huang, B., Ye, F., Wang, W., & Tan, W. (2021) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001687 · Cited by 10
SNP and Phylogenetic Characterization of Low Viral Load SARS-CoV-2 Specimens by Target Enrichment
Orf, G. S., Forberg, K., Meyer, T. V., Mowerman, I., Mohaimani, A., Faron, M. L., Jennings, C., LANDAY, A. L., Goldstein, D., Fox, A. S., et al. (2021) · Frontiers in Virology · doi:10.3389/fviro.2021.765974 · Cited by 10
Spread of variants of epidemic disease based on the microscopic numerical simulations on networks
Okabe, Y., & Shudo, A. (2022) · Scientific Reports · doi:10.1038/s41598-021-04520-0 · Cited by 11
Griffith, G. J., Owen, G. E., Manley, D., Howe, L. D., & Smith, G. D. (2022) · Health & Place · doi:10.1016/j.healthplace.2022.102848 · Cited by 10
Variational Phylodynamic Inference Using Pandemic-scale Data
Ki, C., & Terhorst, J. (2022) · Molecular Biology and Evolution · doi:10.1093/molbev/msac154 · Cited by 9
Assessing Public Health and Social Measures Against COVID-19 in Japan From March to June 2021
Hayashi, K., Kayano, T., Anzai, A., Fujimoto, M., Linton, N. M., Sasanami, M., Suzuki, A., Kobayashi, T., Otani, K., Yamauchi, M., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.937732 · Cited by 11
Lockdowns exert selection pressure on overdispersion of SARS-CoV-2 variants
Nielsen, B. F., Eilersen, A., Simonsen, L., & Sneppen, K. (2022) · Epidemics · doi:10.1016/j.epidem.2022.100613 · Cited by 10
Assessing the Impact of SARS-CoV-2 Lineages and Mutations on Patient Survival
Loucera, C., Pérez-Florido, J., Casimiro‐Soriguer, C. S., Ortuño, F. M., Carmona, R., Bostelmann, G., Martínez-González, L. J., Muñoyerro-Muñiz, D., Villegas, R., Rodríguez‐Baño, J., et al. (2022) · Viruses · doi:10.3390/v14091893 · Cited by 11
Genomic landscape of alpha-variant of SARS-CoV-2 circulated in Pakistan
Fiaz, N., Zahoor, I., Saima, S., & Basheer, A. (2022) · PLoS ONE · doi:10.1371/journal.pone.0276171 · Cited by 11
Zárate, S., Taboada, B., Rosales-Rivera, M., García-López, R., Muñoz‐Medina, J. E., Sánchez‐Flores, A., Herrera‐Estrella, A., Gómez‐Gil, B., Mojica, N. S., Salas-Lais, Á. G., et al. (2023) · Viruses · doi:10.3390/v15010243 · Cited by 10
Pérez-Florido, J., Casimiro‐Soriguer, C. S., Ortuño, F. M., Fernández-Rueda, J. L., Aguado, A., Lara, M., Riazzo, C., Rodríguez‐Iglesias, M., Camacho‐Martínez, P., Merino-Díaz, L., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032419 · Cited by 10
Riley, S., Walters, C. E., Wang, H., Eales, O. D., Haw, D., Ainslie, K. E. C., Atchison, C. J., Fronterrè, C., Diggle, P. J., Ashby, D., et al. (2021) · medRxiv · doi:10.1101/2021.02.18.21251973 · Cited by 10
Quantification of the spread of SARS-CoV-2 variant B.1.1.7 in SwitzerlandPreprint
Chen, C., Nadeau, S., Topolsky, I., Manceau, M., Huisman, J. S., Jablonski, K. P., Fuhrmann, L., Dreifuss, D., Jahn, K., Beckmann, C., et al. (2021) · medRxiv · doi:10.1101/2021.03.05.21252520 · Cited by 10
Smyth, D. S., Trujillo, M., Cheung, K., Gao, A., Hoxie, I., Kannoly, S., Kubota, N., Markman, M., San, K. M., Sompanya, G., et al. (2021) · medRxiv · doi:10.1101/2021.03.21.21253978 · Cited by 10
FFP3 respirators protect healthcare workers against infection with SARS-CoV-2Preprint
Ferris, M., Ferris, R., Workman, C., O'Connor, E., Enoch, D., Goldesgeyme, E., Quinnell, N., Patel, P., Wright, J., Martell, G., et al. (2021) · doi:10.22541/au.162454911.17263721/v2 · Cited by 10
Impact of temperature on the affinity of SARS-CoV-2 Spike for ACE2Preprint
Prévost, J., Richard, J., Gasser, R., Ding, S., Fage, C., Anand, S. P., Adam, D., Vergara, N. G., Tauzin, A., Benlarbi, M., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.07.09.451812 · Cited by 10
A Delay Differential Equation approach to model the COVID-19 pandemicPreprint
Kiselev, I. N., Akberdin, I. R., & Kolpakov, F. (2021) · medRxiv · doi:10.1101/2021.09.01.21263002 · Cited by 10
Yang, X. (2021) · Research Square · doi:10.21203/rs.3.rs-999390/v1 · Cited by 10
Brizzi, A., Whittaker, C., Servo, L. M. S., Hawryluk, I., Junior, C. A. P., de Souza, W. M., Aguiar, R. S., de Araújo, L. J. T., Bastos, L. S., Blenkinsop, A., et al. (2021) · medRxiv · doi:10.1101/2021.11.01.21265731 · Cited by 10
Self-citationScott, J. A., Gandy, A., Mishra, S., Bhatt, S., Flaxman, S. R., Unwin, H. J. T., & Ish-Horowicz, J. (2021) · arXiv (Cornell University) · doi:10.48550/arxiv.2110.12461 · Cited by 10
Self-citationTang, H., Qin, H., He, S., Li, Q., Xu, H., Sun, M., Li, J., Lu, S., Luo, S., Mao, P., et al. (2023) · Advanced Science · doi:10.1002/advs.202207098 · Cited by 8
d’Onofrio, A., Iannelli, M., Marinoschi, G., & Manfredi, P. (2024) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2024.111881 · Cited by 9
Autoimmune hepatitis under the COVID-19 veil: an analysis of the nature of potential associations
Yu, C., Wang, W., Zhang, Q., & Jin, Z. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1510770 · Cited by 9
The speed of vaccination rollout and the risk of pathogen adaptation
Gandon, S., Lambert, A., Voinson, M., Day, T., & Parsons, T. L. (2025) · Journal of The Royal Society Interface · doi:10.1098/rsif.2025.0060 · Cited by 7
Nyberg, T., Harman, K., Zaidi, A., Seaman, S. R., Andrews, N. J., Nash, S., Charlett, A., Bernal, J. L., Myers, R. E., Groves, N., et al. (2022) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiac063 · Cited by 9
Self-citationAshford, F. B., Best, A., Dunn, S. J., Ahmed, Z., Siddiqui, H., Melville, J., Wilkinson, S., Mirza, J. D., Cumley, N., Stockton, J., et al. (2022) · Journal of Clinical Microbiology · doi:10.1128/jcm.02408-21 · Cited by 9
Self-citationMeyer, E. D., Sandfort, M., Bender, J. K., Matysiak‐Klose, D., Dörre, A., Bojara, G., Beyrer, K., & Hellenbrand, W. (2022) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.13051 · Cited by 9
Kobayashi, Y., Arashiro, T., Otsuka, M., Tsuchihashi, Y., Takahashi, T., Arima, Y., Ko, Y., Otani, K., Yamauchi, M., Kamigaki, T., et al. (2022) · Western Pacific surveillance response journal · doi:10.5365/wpsar.2022.13.3.943 · Cited by 9
Borghi, M., Gallinaro, A., Pirillo, M. F., Canitano, A., Michelini, Z., Angelis, M. L. D., Cecchetti, S., Tinari, A., Falce, C., Mariotti, S., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1147953 · Cited by 9
Humoral and cellular immunity against diverse SARS-CoV-2 variants
Chen, C., Wang, X., & Zhang, Z. (2023) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2023.10.003 · Cited by 10
SARS-CoV-2 NSP12 associates with TRiC and the P323L substitution acts as a host adaption
Alruwaili, M., Armstrong, S. D., Prince, T., Erdmann, M., Matthews, D. A., Luu, L., Davidson, A. D., Aljabr, W. A., & Hiscox, J. A. (2023) · Journal of Virology · doi:10.1128/jvi.00424-23 · Cited by 9
Ward, T., Morris, M., Gelman, A., Carpenter, B., Ferguson, W., Overton, C. E., & Fyles, M. (2023) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1011580 · Cited by 9
Taboada, B., Zárate, S., García-López, R., Muñoz‐Medina, J. E., Gómez‐Gil, B., Herrera‐Estrella, A., Sánchez‐Flores, A., Salas-Lais, Á. G., Roche, B., Martínez-Morales, G. B., et al. (2023) · Microbial Genomics · doi:10.1099/mgen.0.001120 · Cited by 9
Phylogenomic early warning signals for SARS-CoV-2 epidemic waves
Drake, K. O., Boyd, O., Franceschi, V. B., Colquhoun, R., Ellaby, N. A. F., & Volz, E. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2023.104939 · Cited by 8
Self-citationGallais, F., Pible, O., Gaillard, J., Debroas, S., Batina, H., Ruat, S., Sandron, F., Delafoy, D., Gerber, Z., Olaso, R., et al. (2021) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-021-03401-9 · Cited by 9
Computation of COVID-19 epidemiological data in Hungary using dynamic model inversion
Csutak, B., Polcz, P., & Szederkényi, G. (2021) · IEEE International Symposium on Applied Computational Intelligence and Informatics (SACI) · doi:10.1109/saci51354.2021.9465563 · Cited by 9
Yokoyama, A. P. H., Wendel, S., Bub, C. B., Fachini, R. M., Dametto, A. P. F., Ferreira, F. S. B., Dutra, V. D. F., Candelaria, G. D. T. P., Sakashita, A. M., Machado, R. R. G., et al. (2021) · Transfusion · doi:10.1111/trf.16573 · Cited by 12
Young, R., Solis, C. J., Barriga-Fehrman, A., Abogabir, C., Thadani, A. R., Labarca, M., Bustamante, E. I., Tapia, C. V., Sarda, A. G., Sepúlveda, F., et al. (2021) · eLife · doi:10.7554/elife.70333 · Cited by 9
Vaccine development and technology for SARS‐CoV‐2: Current insight
Cattel, L., Giordano, S., Traina, S., Lupia, T., Corcione, S., Angelone, L., Valle, G. L., Rosa, F. G. D., & Cattel, F. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27425 · Cited by 7
Abdulnoor, M., Eshaghi, A., Perusini, S. J., Broukhanski, G., Corbeil, A., Cronin, K. I., Fittipaldi, N., Forbes, J. D., Guthrie, J. L., Kus, J. V., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.00681-21 · Cited by 9
Jahn, M., Korth, J., Dorsch, O., Anastasiou, O. E., Krawczyk, A., Brochhagen, L., van de Sand, L., Sorge-Hädicke, B., Tyczynski, B., Witzke, O., et al. (2022) · Vaccines · doi:10.3390/vaccines10020327 · Cited by 9
SARS-CoV-2 variants of concern dominate in Lahore, Pakistan in April 2021
Sarwar, M. B., Yasir, M., Alikhan, N.-F., Afzal, N., Martins, L. D. O., Le-Viet, T., Trotter, A. J., Prosolek, S. J., Kay, G. L., Foster-Nyarko, E., et al. (2021) · Microbial Genomics · doi:10.1099/mgen.0.000693 · Cited by 9
Ding, Z., Chen, T., Lan, J., & Wong, G. (2022) · Biosafety and Health · doi:10.1016/j.bsheal.2022.05.001 · Cited by 9
Structural basis of Omicron immune evasion: A comparative computational study
Contractor, D., Globisch, C., Swaroop, S., & Jain, A. K. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.105758 · Cited by 10
Prerequisite for COVID-19 Prediction: A Review on Factors Affecting the Infection Rate
Tang, S. G. H., Hadi, M. H. H., Arsad, S. R., Ker, P. J., Ramanathan, S., Afandi, N. A. M., Afzal, M. M., Yaw, M. W., Krishnan, P. S., Chen, C. P., et al. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192012997 · Cited by 10
In silico analysis of SARS-CoV-2 genomes: Insights from SARS encoded non-coding RNAs
Periwal, N., Bhardwaj, U., Sarma, S., Arora, P., & Sood, V. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.966870 · Cited by 9
Qin, B., Hu, Z., Liu, W., Sun, Y., Wang, Y., Zhang, H., Yang, F., & He, Y. (2023) · Risk Management and Healthcare Policy · doi:10.2147/rmhp.s404478 · Cited by 9
Phylodynamic of SARS-CoV-2 during the second wave of COVID-19 in Peru
Arévalo, S. J., Calampa, C. S. U., Jiménez-Silva, C. L., Aguilar, M. Q., Bouckaert, R., & Pinho, J. R. R. (2023) · Nature Communications · doi:10.1038/s41467-023-39216-8 · Cited by 9
Fryer, H. R., Golubchik, T., Hall, M. D., Fraser, C., Hinch, R., Luca Ferretti, A., Thomson, L., Nurtay, A., Pellis, L., House, T., et al. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011461 · Cited by 10
Nan, X., Hardinge, P., Hoehn, S., Dighe, S. N., Ukeri, J., Pease, D. F., Griffin, J., Warrington, J. I., Saud, Z., Hottinger, E., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-47289-0 · Cited by 9
In-Host Flat-like Quasispecies: Characterization Methods and Clinical Implications
Gregori, J., Colomer‐Castell, S., Ibañez‐Lligoña, M., García‐Cehic, D., de Campos, C. F., Buti, M., Riveiro‐Barciela, M., Andrés, C., Piñana, M., Gónzalez‐Sánchez, A., et al. (2024) · Microorganisms · doi:10.3390/microorganisms12051011 · Cited by 9
Asai, N., Nakamura, A., Sakanashi, D., Koita, I., Ohashi, W., Kawamoto, Y., Miyazaki, N., Ohno, T., Yamada, A., Chida, S., et al. (2021) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2021.09.011 · Cited by 9
Implications of a highly transmissible variant of SARS-CoV-2 for children
Ratmann, O., Bhatt, S., & Flaxman, S. R. (2021) · Archives of Disease in Childhood · doi:10.1136/archdischild-2021-321903 · Cited by 9
Self-citationSARS-COV-2 δ variant drives the pandemic in the USA through two subvariantsPreprint
Yang, X. (2021) · Research Square · doi:10.21203/rs.3.rs-986605/v1 · Cited by 9
SARS-COV-2 C.1.2 variant is highly mutated but may possess reduced affinity for ACE2 receptorPreprint
Yang, X. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.16.464644 · Cited by 10
Lythgoe, K., Golubchik, T., Hall, M. D., House, T., Cahuantzi, R., MacIntyre-Cockett, G., Fryer, H. R., Thomson, L., Nurtay, A., Ghafani, M., et al. (2022) · medRxiv · doi:10.1101/2022.01.05.21268323 · Cited by 9
Self-citationBakshi, R., Kaur, S., Kaur, K., Kaur, R., Boparai, J. K., Ghai, R., Kaur, T., Kaur, A., Kaur, J., Verma, K., et al. (2021) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.15.4.07 · Cited by 8
Saravia-Butler, A., Schisler, J. C., Taylor, D. M., Beheshti, A., Butler, D., Meydan, C., Foox, J., Hernandez, K. M., Mozsary, C., Mason, C. E., et al. (2022) · iScience · doi:10.1016/j.isci.2022.105310 · Cited by 8
Zhang, D., Kukkar, D., Kim, K., & Bhatt, P. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.129284 · Cited by 6
Bhiman, J. N., & Moore, P. L. (2022) · Immunological Reviews · doi:10.1111/imr.13086 · Cited by 7
Ahmed, S. S., Al-Mamun, A., Hossain, S. I., Akter, F., Ahammad, I., Chowdhury, Z. M., & Salimullah, M. (2022) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2022.2111361 · Cited by 8
Kawakami, Y., Nojiri, S., Nakamoto, D., Irie, Y., Miyazawa, S., Kuroki, M., & Nishizaki, Y. (2023) · Scientific Reports · doi:10.1038/s41598-022-27322-4 · Cited by 8
Guest, P. C., Kesharwani, P., Butler, A. E., & Sahebkar, A. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-28012-2_1 · Cited by 8
Dynamic analysis of SARS-CoV-2 evolution based on different countries
Xiao, B., Wu, L., Sun, Q., Shu, C., & Hu, S. (2024) · Gene · doi:10.1016/j.gene.2024.148426 · Cited by 9
Rajput, V., Pramanik, R. S., Nannaware, K., Malik, V., Matra, S., Kumar, S., Joshi, S., Kadam, P., Bhalerao, U., Tupekar, M. M., et al. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.176833 · Cited by 8
Short Communication:Evidence of Novel SARS-CoV-2 Variants Circulation in Romania
Surleac, M. D., Casangiu, C., Bănică, L. M., Milu, P., Florea, D., Săndulescu, O., Streinu‐Cercel, A., Vlaicu, O., Tudor, A., Hohan, R., et al. (2021) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2021.0009 · Cited by 9
Prakoeswa, F. R. S., Awanis, G. S., Azizah, A., Prasetyo, B., Martini, S., Soebono, H., Husada, D., Notobroto, H. B., Listiawan, M. Y., Endaryanto, A., et al. (2021) · African Journal of Infectious Diseases · doi:10.21010/ajid.v15i2.9 · Cited by 7
Dimeglio, C., Milhes, M., Loubes, J., Ranger, N., Mansuy, J., Trémeaux, P., Jeanne, N., Latour, J., Nicot, F., Donnadieu, C., et al. (2021) · Viruses · doi:10.3390/v13050898 · Cited by 8
Lockdown as a last resort option in case of COVID-19 epidemic rebound: a modelling study
Kiem, C. T., Crépey, P., Bosetti, P., Lévy-Bruhl, D., Yazdanpanah, Y., Salje, H., Boëlle, P., & Cauchemez, S. (2021) · Eurosurveillance · doi:10.2807/1560-7917.es.2021.26.22.2001536 · Cited by 8
Metadata
- Authors
- The COVID-19 Genomics UK (COG-UK) consortium, Volz, E., Mishra, S., Chand, M., Barrett, J. C., Johnson, R., Geidelberg, L., Hinsley, W. R., Laydon, D. J., Dabrera, G., O’Toole, Á., Amato, R., Ragonnet-Cronin, M., Harrison, I., Jackson, B., Ariani, C. V., Boyd, O., Loman, N. J., McCrone, J. T., Gonçalves, S., Jorgensen, D., Myers, R., Hill, V., Jackson, D. K., Gaythorpe, K., Groves, N., Sillitoe, J., Kwiatkowski, D. P., Flaxman, S., Ratmann, O., Bhatt, S., Hopkins, S., Gandy, A., Rambaut, A., & Ferguson, N. M.
- Affiliations
- Imperial College London (GB)
- Public Health England (GB)
- Wellcome Sanger Institute (GB)
- University of Edinburgh (GB)
- University of Copenhagen (DK)
- Corresponding author
- Volz, Erik
- Ferguson, Neil M.
- ORCID
- Volz, Erik
- Mishra, Swapnil
- Chand, Meera
- Barrett, Jeffrey C.
- Geidelberg, Lily
- Hinsley, Wes R.
- Laydon, Daniel J.
- Dabrera, Gavin
- Harrison, Ian
- Jackson, Ben
- Ariani, Cristina V.
- Boyd, Olivia
- Loman, Nicholas J.
- McCrone, John T.
- Gonçalves, Sónia
- Jorgensen, David
- Myers, Richard
- Hill, Verity
- Jackson, David K.
- Gaythorpe, Katy
- Groves, Natalie
- Kwiatkowski, Dominic P.
- Flaxman, Seth
- Ratmann, Oliver
- Bhatt, Samir
- Hopkins, Susan
- Gandy, Axel
- Rambaut, Andrew
- Ferguson, Neil M.
- Venue
- Nature
- Published
- 2021-03-25
- Volume
- 593
- Issue
- 7858
- Pages
- 266-269
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W3136588845
- Cited by
- 1,611
- References
- 32
- Citations by year
- 2026: 38 · 2025: 86 · 2024: 116 · 2023: 216 · 2022: 464 · 2021: 685
- FWCI
- 116.92
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Nature (publishedVersion)
- medRxiv (acceptedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- UEA Digital Repository (University of East Anglia) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion)
- Research Portal (King's College London) (submittedVersion, other-oa)
- Northumbria Research Link (Northumbria University) (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, other-oa)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Spiral (Imperial College London) (submittedVersion, cc-by)
- Spiral (Imperial College London) (submittedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Apollo
- Funders
- Bill and Melinda Gates Foundation (OPP 1175094, 206194, OPP1197730, MR/R015600/1, OPP1084362)
- Wellcome Trust (MR/R015600/1, 204911/Z/16/Z, Z/17/Z, 206298/Z/17/Z, RDA02, 206298, 206194)
- UK Research and Innovation (MR/V038109/1, MR/R015600/1, MC_PC_19027)
- National Institute for Health Research Health Protection Research Unit
- Cancer Research UK (23923)
- National Institute for Health and Care Research (PR-OD-1017–20002, MR/R015600/1, RDA02, NIHR301445, OPP1175094, ACF-2018-04-014)
- Academy of Medical Sciences (AMS-CSF4-Torok, SBF004\1080)
- Imperial College London (MR/R015600/1)
- European Commission (725422, MR/R015600/1, 101003653, COVID-19, 206298/Z/17/Z)
- Rural Development Administration
- Novo Nordisk (NNF20OC0059309)
- Novo Nordisk Fonden (NNF20OC0059309)
- Medical Research Council (MR/R015600/1, MR/M006212/1, MC_PC_19026, MR/V038109/1, MR/S00291X/1, MC_PC_19012, COVID-19)
- Engineering and Physical Sciences Research Council (EP/V002910/1, EP/V002910/2)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 detection and testing
- Keywords
- SARS-CoV-2, B.1.1.7 lineage, variants of concern, transmissibility, S-gene target failure, time-varying reproduction number, viral genomic surveillance, COVID-19 pandemic, England
- MeSH terms
- COVID-19, SARS-CoV-2, Adolescent, Adult, Aged, Aged, 80 and over, Child, Child, Preschool, England, Humans, Infant, Infant, Newborn, Middle Aged, Phylogeny, Time Factors, Genome, Viral, Age Distribution, Evolution, Molecular, Basic Reproduction Number, Young Adult, Spike Glycoprotein, Coronavirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
